These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 9411786)
1. Drug companies decline to cooperate. Williams N Science; 1997 Dec; 278(5344):1704. PubMed ID: 9411786 [No Abstract] [Full Text] [Related]
2. Public-private partnership: from there to here. Croft SL Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S9-14. PubMed ID: 16087204 [TBL] [Abstract][Full Text] [Related]
3. [Commercialization of results of intellectual activities in pharmaceutical industry]. Posylkina OV; Timaniuk VN; Gladukh EV Lik Sprava; 2002; (8):16-9. PubMed ID: 12669531 [TBL] [Abstract][Full Text] [Related]
4. Japanese companies join international fight against malaria. Saegusa A Nature; 1999 Oct; 401(6756):832. PubMed ID: 10553889 [No Abstract] [Full Text] [Related]
5. Commentary: learning all the lessons: expanding access to malaria diagnosis and treatment. von Schoen-Angerer T J Public Health Policy; 2013 May; 34(2):315-9. PubMed ID: 23536100 [TBL] [Abstract][Full Text] [Related]
6. Public health. From financing to fevers: lessons of an antimalarial subsidy program. Laxminarayan R; Arrow K; Jamison D; Bloom BR Science; 2012 Nov; 338(6107):615-6. PubMed ID: 23118173 [No Abstract] [Full Text] [Related]
7. Malaria. As drug pilot wraps up, a lively debate about its future. Enserink M Science; 2012 Nov; 338(6108):732-3. PubMed ID: 23139306 [No Abstract] [Full Text] [Related]
8. Developing drugs for parasitic diseases. Andreopoulos S Science; 2003 Apr; 300(5618):430-1. PubMed ID: 12702858 [No Abstract] [Full Text] [Related]
9. [Intervention against malaria requires international solidarity. Institutions and drug industry should find new forms of collaboration]. Björkman A Lakartidningen; 2004 Jan; 101(5):384-8. PubMed ID: 14986448 [No Abstract] [Full Text] [Related]
10. Public health. Optimizing investments in malaria treatment and diagnosis. Cohen JM; Woolsey AM; Sabot OJ; Gething PW; Tatem AJ; Moonen B Science; 2012 Nov; 338(6107):612-4. PubMed ID: 23118172 [No Abstract] [Full Text] [Related]
11. WIPO Re:Search: a consortium catalyzing research and product development for neglected tropical diseases. Dent J; Ramamoorthi R; Graef K; Nelson LM; Wichard JC Pharm Pat Anal; 2013 Sep; 2(5):591-6. PubMed ID: 24237166 [No Abstract] [Full Text] [Related]
12. [ASAQ, a breakthrough in the fight against malaria]. Kiechel JR; Pécoul B Med Trop (Mars); 2007 Apr; 67(2):109-10. PubMed ID: 17691424 [No Abstract] [Full Text] [Related]
13. What role can public health institutions play in drug development for the poor? A case study of artesunate. Gomes M; Olliaro P; Folb P Med Trop (Mars); 1998; 58(3 Suppl):97-100. PubMed ID: 10212912 [TBL] [Abstract][Full Text] [Related]
14. Winning the drugs war. Ridley R; Toure Y Nature; 2004 Aug; 430(7002):942-3. PubMed ID: 15318240 [No Abstract] [Full Text] [Related]
15. From the core to the peripheries: multilateral governance of malaria in a multi-cultural world. Aginam O Chic J Int Law; 2002; 3(1):87-103. PubMed ID: 15709301 [No Abstract] [Full Text] [Related]
16. Staying ahead of the fourth horseman. Rex JH Nat Rev Microbiol; 2004 Sep; 2(9):684. PubMed ID: 15378807 [No Abstract] [Full Text] [Related]
17. Drug discovery and beyond: the role of public-private partnerships in improving access to new malaria medicines. Nwaka S Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S20-9. PubMed ID: 16085175 [TBL] [Abstract][Full Text] [Related]
18. Initial lessons from public-private partnerships in drug and vaccine development. Wheeler C; Berkley S Bull World Health Organ; 2001; 79(8):728-34. PubMed ID: 11545329 [TBL] [Abstract][Full Text] [Related]
19. MMV: New Medicines for Malaria Venture. TDR News; 1999 Feb; (58):2, 4. PubMed ID: 12322122 [TBL] [Abstract][Full Text] [Related]